by Truveta Research | Jun 6, 2023 | Research, Research Insights
Beginning in Fall 2022, the news media has reported extensively on the use of Glucagon-like peptide-1 receptor agonist (GLP-1s) for weight loss (Belluz, 2023). Physicians have taken to TikTok to promote GLP-1s for weight loss, and celebrities & influencers – such...
by Truveta Research | May 9, 2023 | Research, Research Insights
This blog is an extension of our poster presented at ISPOR, titled Real-World Effectiveness of SGLT2 Inhibitors Vs Metformin as First-Line Therapy in Type 2 Diabetes. Individuals with type 2 diabetes mellitus (T2DM) have a higher risk of cardiovascular disease...
by Truveta Research | Apr 30, 2023 | Research, Research Insights
Since the 1990s, the negative impact of prescription opioids – particularly death from overdose – have become an epidemic in the US (Centers for Disease Control and Prevention, 2022; Paulozzi et al., 2011). More recently, in the early 2010s, the US embarked on a new...
by Truveta Research | Apr 27, 2023 | Research, Research Insights
While many adults engage in sports, even more children participate in sports (Blendon et al., 2015). A 2020 report suggests that over 50% of children between 6-17 have participated in sports within the last year (Black et al., 2022), which is an increase from under...
by Truveta Research | Apr 21, 2023 | Research, Research Insights
With over 3.5 million sport injuries estimated to occur each year (Johns Hopkins Medicine, 2023), we spent the last several weeks digging into and describing injury patterns related to specific sports: basketball, soccer, baseball/softball, and football. Although...
by Truveta Research | Apr 21, 2023 | Research, Research Insights
The National Institute of Health estimates that more than six million Americans over the age of 65 suffer from Alzheimer’s disease, with many more under the age of 65 also having the disease (National Institute on Aging, 2021). It is currently ranked as the seventh...
